Franklin Resources’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49B | Buy |
|
|||||
|
2025
Q1 | $1.55B | Buy |
|
|||||
|
2024
Q4 | $1.28B | Buy |
|
|||||
|
2024
Q3 | $1.49B | Buy |
|
|||||
|
2024
Q2 | $1.37B | Buy |
|
|||||
|
2024
Q1 | $1.17B | Buy |
|
|||||
|
2023
Q4 | $660M | Sell |
|
|||||
|
2023
Q3 | $766M | Buy |
|
|||||
|
2023
Q2 | $810M | Sell |
|
|||||
|
2023
Q1 | $825M | Sell |
|
|||||
|
2022
Q4 | $884M | Sell |
|
|||||
|
2022
Q3 | $920M | Sell |
|
|||||
|
2022
Q2 | $1.13B | Buy |
|
|||||
|
2022
Q1 | $1.02B | Buy |
|
|||||
|
2021
Q4 | $588M | Buy |
|
|||||
|
2021
Q3 | $572M | Buy |
|
|||||
|
2021
Q2 | $357M | Sell |
|
|||||
|
2021
Q1 | $307M | Sell |
|
|||||
|
2020
Q4 | $320M | Buy |
|
|||||
|
2020
Q3 | $336M | Sell |
|
|||||
|
2020
Q2 | $361M | Buy |
|
|||||
|
2020
Q1 | $259M | Buy |
|
|||||
|
2019
Q4 | $270M | Buy |
|
|||||
|
2019
Q3 | $240M | Buy |
|
|||||
|
2019
Q2 | $194M | Buy |
|
|||||
|
2019
Q1 | $187M | Buy |
|
|||||
|
2018
Q4 | $173M | Buy |
|
|||||
|
2018
Q3 | $141M | Buy |
|
|||||
|
2018
Q2 | $54.1M | Buy |
|
|||||
|
2018
Q1 | $34.6M | Sell |
|
|||||
|
2017
Q4 | $34.4M | Hold |
|
|||||
|
2017
Q3 | $33.6M | Sell |
|
|||||
|
2017
Q2 | $33.9M | Sell |
|
|||||
|
2017
Q1 | $40.6M | Sell |
|
|||||
|
2016
Q4 | $45.6M | Sell |
|
|||||
|
2016
Q3 | $56.9M | Sell |
|
|||||
|
2016
Q2 | $61.2M | Buy |
|
|||||
|
2016
Q1 | $57.1M | Buy |
|
|||||
|
2015
Q4 | $36.2M | Buy |
|
|||||
|
2015
Q3 | $24M | Buy |
|
|||||
|
2015
Q2 | $1.47M | Sell |
|
|||||
|
2015
Q1 | $1.8M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $13.7M | Sell |
|
|||||
|
2014
Q2 | $257M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $215K | Buy |
|